Measles - Central African Republic

Published on March 6, 2020

WHO Disease Outbreak News

Other news

Clinical trials on for an advanced oral drug for kala-azar

March 6, 2020
Leishmaniasis affects over one billion people; Visceral leishmaniasis(VL) also known as kala-azar is the most serious form of the disease, affects an estimated 50 000 to 90 000 people per year. If left untreated it is almost always fatal. After malaria, it is the second largest parasitic killer in the world. A new oral drug for kala-azar that holds the promise of reduced treatment time and fewer s

Estimating the burden of iron deficiency among African children

March 9, 2020
The prevalence of ID is underestimated in African children when defined using the WHO guidelines, especially in malaria-endemic populations, and the use of transferrin saturation may provide a more accurate approach. Further research is needed to identify the most accurate measures for determining the prevalence of ID in sub-Saharan Africa. BMC Medicine